Pharmacological challenge with naloxone and cue exposure in alcohol dependence: Results of a randomized, double-blind placebo-controlled trial

References

• American Psychiatric Association 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press.
   Google Scholar
• Barson JR, Carr AJ, Soun J, Sobhani NC, Rada P, Leibowitz SF, Hoebel BG. 2009. Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. Alcohol Clin Exp Res 34:214–222.
   Google Scholar
• Benkert O, Hippius H. 2007. Kompendium der psychiatrischen Pharmakotherapie. 5th ed. Berlin: Springer.p 415–417.
   Google Scholar
• Berg BJ, Volpicelli JR, Alterman AI. 1992. The relationship of alcohol drinking and endogenous opioids: the opioid compensation hypothesis. In: Naranjo CA, Sellers EM, editors. Novel pharmacological interventions for alcoholism. New York, NY: Springer-Verlag. p 37–47.
   Google Scholar
• Chiang SS, Schuetz CG, Soyka M. 2001. Role of aggressivity on reactivity and craving before and after cue exposure in recently detoxified alcoholics: results from an experimental study. Eur Addict Res 7:184–192.
   Google Scholar
• Chiang SS, Schuetz CG, Soyka M. 2002. Effects of irritability on craving before and after cue exposure in abstinent alcoholic inpatients: experimental data on subjective response and heart rate. Neuropsychobiology 46:150–160.
   Google Scholar
• Chiang SS, Schuetz C, Soyka M. 2005. Effects of cue exposure on the subjective perception of alcohol dependents with different types of cue reactivity. J Neural Transm. 12:1275–1278.
   Google Scholar
• Ciccocioppo R, Martin-Fardon R, Weiss F. 2002. Effect of selective blockade of mu or delta opioid receptors on reinstatement of alcohol-seeking behavoir by drug-associated stimuli in rats. Neuropsychoharmacology 27:391–399.
   PubMed Web of Science ®Google Scholar
• Cowen MS, Lawrence AJ. 1999. The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption. Prog Neuropsychopharmacol Biol Psychiatry 23:1171–1212.
   PubMed Web of Science ®Google Scholar
• Gianoulakis C. 2004. Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem 4:39–50.
   PubMed Web of Science ®Google Scholar
• Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. 2004. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend 74:223–234.
   PubMed Web of Science ®Google Scholar
• Grimm JW, Manaois M, Osincup D, Wells B, Buse C. 2007. Naloxone attenuates incubated sucrose craving in rats. Psychopharmacology 194:537–544.
   PubMed Web of Science ®Google Scholar
• Hernandez-Avila CA, Oncken C, Van Kirk J, Wand G, Kranzler HR. 2002. Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism. Biol Psychiatry 51:652–658.
   PubMed Web of Science ®Google Scholar
• Herz A. 1997. Endogenous opioid systems and alcohol addiction. Psychopharmacology 29:99–111.
   Google Scholar
• Johnson BA, Ait-Daoud N. 2000. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology 149:327–344.
   PubMed Web of Science ®Google Scholar
• June HL, Cummings R, Eiler WJ II, Foster KL, McKay PF, Seyoum R, et al. 2004. Central opioid receptors differentially regulate the nalmefene-induced suppression of ethanol- and saccharinreinforced behaviors in alcohol-preferring (P) rats. Neuropsychopharmacology 29:285–299.
   Google Scholar
• Katner SN, Magalong JG, Weiss F. 1999. Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology 20:471–479.
   PubMed Web of Science ®Google Scholar
• Kemper A, Koalick F, Thiele H, Retzow A, Rathsack R, Nickel B. 1990. Cortisol and β-endorphin response in alcoholics and alcohol abusers following a high naloxone dosage. Drug Alcohol Depend 25:319–326.
   Google Scholar
• Kiefer F, Jiménez-Arriero MA, Klein O, Diehl A, Rubio G. 2008. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone. Addiction Biol 13:124–129.
   PubMed Web of Science ®Google Scholar
• Kreek MJ. 1996. Opiates, opioids and addiction. Mol Psych 1:232–254.
   PubMed Web of Science ®Google Scholar
• Krishnan-Sarin S, Rosen MI, O’Malley S. 1999. Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence. Arch Gen Psychiatry 56:663–668.
   Google Scholar
• Liu X, Weiss F. 2002. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22:7856–7861.
   PubMed Web of Science ®Google Scholar
• Mann K, Kiefer F, Smolka M, Gann H, Wellek S, Heinz A. 2009. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. Alcohol Clin Exp Res 33:674–683.
   PubMed Web of Science ®Google Scholar
• McNair DM, Lorr M, Dropplemann LF, Biehl B, Dangel S. 1986. POMS profile of mood states – Deutsche Bearbeitung von Biehl, Dangel & Reiser (PSYTKOM-Dokumentation in Vorbereitung)/Profile of Mood States (German adaption/author). In Internationale Skalen für Psychiatrie (2. veränderte Auflage), Profile of Mood States. Ein Verfahren zur Messung von Stimmungszuständen. Selbstbeurteilungsskala. In Collegium Internationale Psychiatriae Scalarum (CIPS). Weinheim, Beltz.
   Google Scholar
• Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, et al. 1999. Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23:1386–1394.
   PubMed Web of Science ®Google Scholar
• Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W. 2007. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. Eur Neuropsychopharmacol 17:558–566.
   PubMed Web of Science ®Google Scholar
• Oswald LM, Wand GS. 2004. Opioids and alcoholism. Physiol Behav 81:339–358.
   PubMed Web of Science ®Google Scholar
• Owens MJ, Nemeroff CB. 1991. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:427–473.
   Google Scholar
• Peachey JE, Lei H. 1988. Assessment of opiate dependence with naloxone. Br J Addict 83:193–201.
   PubMedGoogle Scholar
• Pirkola SP, Poikolainen K, Lönnequist JK. 2006. Currently active and remitted alcohol dependence in a nationwide adult general population – Results from the Finnish Health 2000 Study. Alcohol Alcoholism 41:321–327.
   PubMed Web of Science ®Google Scholar
• Rada P, Barson JR, Leibowitz SF, Hoebel BG. 2010. Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens. Brain Res 1312:1–9.
   PubMed Web of Science ®Google Scholar
• Ray LA, Mackillop J, Leggio L, Morgan M, Hutchinson KE. 2009. Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacol Biochem Behav 91:489–494.
   PubMed Web of Science ®Google Scholar
• Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. 2012. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treat­ment: a critical review. Alcohol Clin Exp Res 36:385–394.
   PubMed Web of Science ®Google Scholar
• Rehm J, Room R, van den Brink W, Jacobi F. 2005. Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol 15:377–388.
   PubMed Web of Science ®Google Scholar
• Rösner S, Leucht S, Lehert P, Soyka M. 2008. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes. J Psychopharmacol 22:11–23.
   PubMed Web of Science ®Google Scholar
• Rösner S, Hackl-Herwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. 2010. Opioid Antagonists for alcohol dependence. Cochrane Database Syst Rev 8:CD001867.
   Google Scholar
• Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. 2000. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnormal Psychol 109:738–742.
   PubMed Web of Science ®Google Scholar
• Rosen MI, McMahon TJ, Margolin A, Gill TS, Woods SW, Pearsall HR, et al. 1995. Reliability of sequential naloxone ­challenge tests. Am J Drug Alcohol Abuse 21:453–457.
   Web of Science ®Google Scholar
• Schuetz CG, Koch J, Preuss U, Soyka M. 1997. Reliability and validity of the German version of the 47-item Craving Questionaire and the 49-item Addiction Research Center Inventory. Nashville, TN: Build Int Res Infrastruct Field Drug Abuse.
   Google Scholar
• Spanagel R, Zieglgansberger W. 1997. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54–59.
   PubMed Web of Science ®Google Scholar
• Trigo JM, Martin-Garcia E, Berrendero F, et al. 2010. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend 108:183–194.
   PubMed Web of Science ®Google Scholar
• Volpicelli JR, Ulm RR, Hopson N. 1991. Alcohol drinking in rats during and following morphine injection. Alcohol 8:289–292.
   Google Scholar
• Wand GS, Mangold D, El Deiry S, McCaul ME, Hoover D. 1998. Family history of alcoholism and hypothalamic opioidergic activity. Arch Gen Psychiatry 55:1114–1119.
   PubMedGoogle Scholar
• Wand GS, Weerts EM, Kuwabara H, Frost JJ, Xu X, MaCaul ME. 2011. Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects. Psychoendocrinology 36:1453–1459.
   Google Scholar
• Wand GS, Weerts EM, Kuwabara H, Wong DF, Xu X, McCaul ME. 2012. The relationship between naloxone-induced cortisol and mu opioid receptor availability in mesolimbic structures is disrupted in alcohol dependent subjects. Alcohol 46:511–517.
   Google Scholar
• Wand GS, Weerts EM, Kuwabaar H, Wong DF, Xu X, McCaul ME. 2013. The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects. Addict Biol 18:191–192.
   Google Scholar
• Wild KD, Reid D. 1990. Modulation of ethanol-intake by morphine: evidence of a central site of action. Life Sciences 47:49–54.
   Google Scholar
• Wittchen H-U, Semmler G. 1990. Composite International Diagnostic Interview (CIDI). Beltz, Weinheim.
   Google Scholar